Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Dihexa for Sale > Dihexa 1401708-83-5 High Purity Peptide Powder with factory wholesale
Dihexa  1401708-83-5 High Purity Peptide Powder with factory wholesale buy - large image1
Dihexa  1401708-83-5 High Purity Peptide Powder with factory wholesale buy - image1
Dihexa  1401708-83-5 High Purity Peptide Powder with factory wholesale buy - image2
Dihexa  1401708-83-5 High Purity Peptide Powder with factory wholesale buy - image3
Dihexa  1401708-83-5 High Purity Peptide Powder with factory wholesale buy - image4
Dihexa  1401708-83-5 High Purity Peptide Powder with factory wholesale buy - image5
Dihexa  1401708-83-5 High Purity Peptide Powder with factory wholesale buy - image6

Dihexa 1401708-83-5 High Purity Peptide Powder with factory wholesale

TDS 180 Inquiries

Unit Price:

$4.16-4.46/BOU FOB

Get Latest Price
CAS No.:

1401708-83-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

China

Brand:

Runlian or as clients' requirement

Packaging:

box

Price valid (until):

2027-12-30

Company Type:
Trader
Location:
China
Average Lead Time:
15 days
Qualification:
Main Products:

peptide

  • Product Details

  • Seller Information

  • History Price

  • Inquiry History

  • Description

    Sales Manager: Judy
    Whatsapp: +86 15227650217
    Email: 17334330163@163.com
    Cartalax – Full Product Description (English, Professional Version)


    Basic Information


    • Product Name: Cartalax
    • Item No.: LAX20
    • Specification: 20mg × 10 vials
    • Appearance: White lyophilized powder, sterile, highly soluble
    • Purity: ≥98% (HPLC tested)
    • Formula: Ala‑Glu‑Asp (AED tripeptide)
    • Class: Tissue‑specific bioregulator peptide (cartilage‑targeted)
    • Price: $95
    • Usage: For laboratory research use only



    Core Functions & Mechanisms


    Cartalax is a synthetic cartilage bioregulator peptide that acts at the gene‑expression level to protect, repair, and maintain articular cartilage and connective tissues.

    1. Epigenetic & Gene Regulation

      • Binds directly to chondrocyte DNA promoter regions
      • Upregulates SOX9 (master chondrogenic transcription factor)
      • Boosts expression of COL2A1 (type II collagen), aggrecan (ACAN), and COMP
      • Reduces catabolic pathways driven by Runx2, MMP‑13, ADAMTS‑5

    2. Anabolic Cartilage Repair

      • Stimulates chondrocyte proliferation and viability
      • Increases synthesis of proteoglycans and glycosaminoglycans (GAGs)
      • Strengthens extracellular matrix (ECM) structure and elasticity
      • Reduces chondrocyte apoptosis and senescence

    3. Anti‑Inflammatory & Protective Action

      • Lowers pro‑inflammatory cytokines (IL‑1β, TNF‑α, NF‑κB)
      • Inhibits cartilage‑degrading enzymes
      • Reduces joint discomfort and swelling in preclinical models
      • Protects against mechanical stress and age‑related degeneration

    4. Joint & Spine Support

      • Maintains articular cartilage thickness and integrity
      • Supports intervertebral disc health and hydration
      • Assists recovery in post‑traumatic and post‑surgical joint research models
      • Improves mobility and functional resilience in aging connective tissue




    Key Research Applications


    • Osteoarthritis (OA) cartilage protection and repair
    • Joint injury rehabilitation and post‑operative recovery
    • Age‑related cartilage loss and mobility decline
    • Spine health and intervertebral disc research
    • Connective tissue aging and senescence studies
    • Sports medicine and overuse injury models



    Advantages


    • Tissue‑specific: Targets cartilage without broad systemic effects
    • Gene‑level action: Restores natural chondrocyte function
    • High purity: ≥98% HPLC; consistent research results
    • Stable formulation: Lyophilized for long‑term storage
    • Well‑studied: Supported by decades of bioregulator peptide research

      1. Basic Product Information
      Parameter Specification / Value
      Product Name Cartalax
      Common Aliases Ala-Glu-Asp, AED Tripeptide, Cartilage Bioregulator Peptide
      Item No. LAX20
      Product Category Tissue-specific Bioregulator Peptide (Cartilage-targeted)
      Intended Use For laboratory research use only
      Brand Generic research-grade peptide (no proprietary brand in price list)
      Origin Synthetic (chemically synthesized peptide)





      Product Detail  


    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 1
    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 2
    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 3
    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 4
    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 5
    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 6
    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 7
    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 8
    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 9
    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 10
    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 11
    What is Cartalax?

    Cartalax (AED) is a synthetic tripeptide bioregulator developed by Professor Vladimir Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology. It consists of three amino acids: Alanine, Glutamic Acid, Aspartic Acid. As a cartilage-targeted peptide, it supports joint health and connective tissue repair by regulating gene expression in chondrocytes.
    Key Benefits
    • ✅ Cartilage Regeneration: Promotes type II collagen and proteoglycan synthesis.
    • ✅ Anti-Inflammatory: Inhibits MMPs, IL-1β, TNF-α; reduces joint inflammation.
    • ✅ Joint Mobility: Improves flexibility, relieves stiffness, supports long-term skeletal wellness.
    • ✅ High Bioavailability: Small molecular size ensures rapid absorption and targeted action.

    Applications

    • Research: Osteoarthritis, cartilage degeneration, age-related joint decline.
    • Formulation: Dietary supplements, joint health products, peptide therapy formulations.
    • Sports Nutrition: Post-injury recovery, connective tissue support, mobility enhancement.

    Storage & Handling

    • Long-term: Store at -20°C in a dry, dark place.
    • After reconstitution: Keep at 2–8°C and use within 7 days.
    • Avoid: Repeated freeze-thaw cycles, moisture, and direct sunlight.
    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 12
    Shop Cartalax CAS NO. 45234-02-4 Raw Peptide Factory Supply High Quality Low Price-Detailed Image 13


     

    —— FAQ ——

     

    1.Can we get your free samples?
    Yes, can. Our free sample can be provided for customers test. But the freight for express is obuyer's account.


    2.How to make an order?
    Send me message and let me know what you need with quantity , then i will calculate to you.


    3.Can we do printing or label on the bottles?
    Yes, can. We can offer various printing ways,such, screen printing, hot stamping, label printing.


    4.What is the normal lead time?
    For stock products, within 24-48 hours after we receive your payment. For smaller customize color bottles, we will ship out within 3-15 days.


    5.What is your shipping terms?
    Faster ways: EDEX, DHL, UPS, TNT, etc by sea or by air economy


    Pls input...

    ECHEMI Editorial Reference

    Dihexa is a synthetic peptide-based compound and angiotensin IV analog. As a research and pharmaceutical raw material, Dihexa is characterized by its defined molecular structure and peptide properties. It is primarily used for research, analytical testing, compound evaluation, and pharmaceutical development.

    Certificates
    • Dihexa  1401708-83-5 High Purity Peptide Powder with factory wholesale Certificates 1 TDS

    Basic Info
    Product Name:

    Dihexa

    Other Name:

    L-Isoleucinamide,N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-;N-(1-Oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-L-isoleucinamide;Dihexa;N-Hexanoic-Tyr-Ile-(6)aminohexanoic amide

    CAS No.:

    1401708-83-5

    Molecular Formula:

    C27H44N4O5

    InChIKeys:

    InChIKey=XEUVNVNAVKZSPT-JTJYXVOQSA-N

    Molecular Weight:

    504.7

    Exact Mass:

    504.66

    Characteristics
    Density:

    1.111±0.06 g/cm3(Predicted)

    Boiling Point:

    866.2±65.0 °C(Predicted)

    Research
    Class:

    Angiotensin IV-derived oligopeptide / HGF-c-Met potentiator

    Status:

    Research compound — Not FDA approved

    Mechanism:

    A synthetic, orally active, blood-brain-barrier-permeable oligopeptide (Hexanoyl-Tyr-Ile-Ahx-NH₂) derived from angiotensin IV. Dihexa binds hepatocyte growth factor (HGF) with high affinity (Kd = 65 pM) and allosterically potentiates HGF activity at its receptor c-Met, promoting dendritic spinogenesis and synaptogenesis. In preclinical models it was reported to be seven orders of magnitude more potent than BDNF at promoting synapse formation. Note: the foundational 2014 paper (McCoy AT, et al. Neurobiol Learn Mem. 2014) was retracted in 2025.

    EC50 (HGF Binding KD):

    65 pM

    Activity note:

    Dihexa is an HGF potentiator, not a direct receptor agonist. It does not activate c-Met alone but markedly augments HGF-induced c-Met activation at low nanomolar HGF concentrations. Functional synaptogenic activity was reported at 10⁻¹°–10⁻⁻ M (original data now subject to retraction).

    Source:

    Original report: McCoy AT, et al. Neurobiol Learn Mem. 2014;115:112-120 (retracted 2025). Benoist CC, et al. J Pharmacol Exp Ther. 2014;351(3):628-637.

    Clinical Development:

    NCT04488419

    References
    PubChem:

    PubChem

    UNII:

    9WYX65A5C2

    Disclaimer:

    Dihexa is NOT FDA-approved or EMA-approved as a medicine. It is a research compound only. The foundational 2014 paper describing its synaptogenic potency was retracted in 2025. Its phosphate prodrug fosgonimeton failed a Phase 2/3 Alzheimer’s trial (LIFT-AD, 2024). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptide

    Location:

    Room A0693, 6th Floor, Building 3, No.5 Lvtai Road, Zhongtai Subdistrict, Yuhang District, Hangzhou City, Zhejiang Province

    Average lead Time:

    15 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    51-100

    Year of Establishment:

    2025

    Company Certificates
    • Hangzhou Zhongshuan Technology Co., Ltd.TR60 COA TR60 COA

    Hangzhou ZhongShuan Technology Co., Ltd. specializes in the R&D and manufacturing of pharmaceutical-grade and healthcare-grade bioactive raw materials and their derivatives, which are widely used in pharmaceuticals, nutraceuticals and cosmetics industries and have gained global recognition for superior bioactivity and safety. Our 100,000-square-meter factory is built in strict compliance with GMP standards, boasting a clean production environment, scientific layout, and complete R&D and manufacturing facilities for deep processing of bioactive raw materials and solvent purification, laying a solid foundation for product quality. We are committed to providing global customers with high-quality products and customized professional solutions, and strive to drive product upgrading across various industries through in-depth cultivation of biotechnology.

    Global Market Reach
    The company's products, with their outstanding quality and stable performance, are exported to over, including the Middle East, South America, North America, Southeast Asia, Africa, Europe, etc., and have accumulated a good reputation in overseas markets. Relying on our professional team and global resource integration capabilities, we fully leverage our geographical and supply chain advantages, continuously optimize localized operations, and effectively help customers reduce costs and improve efficiency while ensuring high-quality products.

    Engaged in Raw Materials for 10+ Years
    We are a biotech enterprise engaged in the R&D, production, and sales of peptides and raw materials for more than 10 years.  The company has complete experimental facilities. Advanced testing instruments ensure the stability of product quality from all aspects. If you're interested in our products, don't hesitate to contact us.

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Inquiry History
    180 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Dihexa

    1 KG Oct 26, 2026
    Thailand

    Dihexa

    1 G Oct 23, 2026
    Australia

    Dihexa

    30 G Oct 19, 2026
    Australia

    Dihexa

    2 G Oct 19, 2026
    United States

    Dihexa

    100 PCS Oct 15, 2026
    United States

    Multi-Product Research Chemical Bulk Sourcing Inquiry

    2.6 KG Oct 8, 2026
    Philippines

    Dihexa

    1 KG Oct 2, 2026
    United States

    dihexa

    10 MG Sep 28, 2026
    Australia

    Dihexa

    1 MT Sep 18, 2026
    United States

    Dihexa

    10 G Sep 9, 2026
    Hungary

    Dihexa

    1 G Sep 7, 2026
    India

    Dihexa

    10 MG Sep 4, 2026
    Spain

    Dihexa

    100 MG Aug 30, 2026
    Spain

    Dihexa

    50 MG Aug 28, 2026
    United Arab Emirates

    Diheza

    1 G Aug 28, 2026
    Norway

    Dihexa

    1 G Aug 26, 2026
    Canada

    Dihexa lyophilized 1401708-83-5

    1  Aug 23, 2026
    Canada

    SHLP2 ; PE-22-28; Dihexa ; TAK-653 ; lyophilized

    10 PCS Aug 23, 2026
    United States

    Dihexa

    1 G Aug 22, 2026
    United States

    Dihexa

    500 G Aug 19, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.